Latest Capacity Expansion News

6K Additive surged to a US$13.3 million half-year revenue, up 73% year-on-year, driven by strong demand in its Powder and Alloy segments. The company is on track to nearly quadruple production capacity by the end of 2026, supported by substantial US government funding and a new EXIM loan facility.

Fenix Resources reported a 131% jump in net profit to $12.47 million for FY26, driven by an 87% surge in revenue amid ongoing production ramp-up and infrastructure investments.

Metal Powder Works secures its biggest-ever purchase order for pure copper powder from Embassy Powdered Metals, marking its debut in the copper infiltration segment and accelerating capacity expansion plans.

LGI Limited posted a robust FY26 with a 35.5% rise in net profit, underpinned by a 33% jump in biogas flows and a $56 million capital raise fueling expansion beyond 80MW.

Emyria has cleared a key operational hurdle by resolving Authorised Prescriber capacity constraints in Perth and Queensland, enabling a planned expansion of treatment days in Q4 2026 through the recruitment of 15 new therapists.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Bega Cheese Limited has delivered a robust FY2026 with a $54.8 million statutory profit, a 6.7% revenue increase, and a raised final dividend of 7.5 cents per share. The company is advancing its strategic growth plans focused on high-protein products, international expansion, and sustainability initiatives.

Superloop has reported a 21.6% revenue increase to $664.3 million and a 33% rise in underlying EBITDA to $122.7 million for FY26, completing its Double Down strategy and launching the SuperCharge29 growth plan targeting over $1 billion in revenue by FY29.

Wagners Holding Company Limited (ASX:WGN) reported a 17% revenue increase to $504 million and a 78.5% surge in net profit after tax to $40.6 million for FY26, driven by strong growth in Construction Materials and Composite Fibre Technologies.

Cryosite Limited delivered robust FY26 results with revenue up 18% to $16.7 million and net profit rising 19%, underpinned by a strategic warehouse acquisition that doubled storage capacity and a cool room expansion.

Regal Asian Investments (ASX:RG8) posted a stellar FY26 with a net profit after tax of $124.8 million, driven by a 52.6% net portfolio return and a 10 cent fully franked final dividend, reflecting strong exposure to Asian semiconductors amid the AI boom.

The Calmer Co. has locked in an exclusive global distribution agreement for its kava extract ingredients, underpinning a potential A$25 million revenue stream over three years across key markets including the US and ASEAN.